Cargando…

Hydroxocobalamin as Rescue Therapy in a Patient With Refractory Amlodipine-Induced Vasoplegia

Vasoplegic syndrome is a type of distributive shock characterized by mean arterial pressure of less than 65 mmHg, with normal to high cardiac output and often refractory to fluid resuscitation, high doses of intravenous vasopressors, and inotropes. It is usually observed after cardiac and solid orga...

Descripción completa

Detalles Bibliográficos
Autores principales: Ayasa, Laith A, Azar, Jehad, Odeh, Anas, Ayyad, Mohammed, Shbaita, Sara, Zidan, Thabet, Awwad, Noor Al-deen, Kawa, Nagham M, Awad, Wafaa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10231868/
https://www.ncbi.nlm.nih.gov/pubmed/37265888
http://dx.doi.org/10.7759/cureus.38400
_version_ 1785051832365613056
author Ayasa, Laith A
Azar, Jehad
Odeh, Anas
Ayyad, Mohammed
Shbaita, Sara
Zidan, Thabet
Awwad, Noor Al-deen
Kawa, Nagham M
Awad, Wafaa
author_facet Ayasa, Laith A
Azar, Jehad
Odeh, Anas
Ayyad, Mohammed
Shbaita, Sara
Zidan, Thabet
Awwad, Noor Al-deen
Kawa, Nagham M
Awad, Wafaa
author_sort Ayasa, Laith A
collection PubMed
description Vasoplegic syndrome is a type of distributive shock characterized by mean arterial pressure of less than 65 mmHg, with normal to high cardiac output and often refractory to fluid resuscitation, high doses of intravenous vasopressors, and inotropes. It is usually observed after cardiac and solid organ transplantation surgeries. Here, we report a 56-year-old female patient who presented with a profound vasoplegia manifesting as lethargy and confusion in the setting of amlodipine toxicity. This case of severe vasoplegia was refractory to all conditional lines of medical management reported in the literature. The mainstay treatment modalities for vasoplegia include volume resuscitation, catecholamines, vasopressin, angiotensin II, and possibly methylene blue in unresponsive cases. Our patient was given hydroxocobalamin in favor of methylene blue, given the history of serotonin reuptake inhibitors use, which would have caused a life-threatening serotonin syndrome. Hydroxycobolamine resulted in a dramatic clinical recovery, suggesting its potentially significant role in refractory vasoplegia.
format Online
Article
Text
id pubmed-10231868
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-102318682023-06-01 Hydroxocobalamin as Rescue Therapy in a Patient With Refractory Amlodipine-Induced Vasoplegia Ayasa, Laith A Azar, Jehad Odeh, Anas Ayyad, Mohammed Shbaita, Sara Zidan, Thabet Awwad, Noor Al-deen Kawa, Nagham M Awad, Wafaa Cureus Emergency Medicine Vasoplegic syndrome is a type of distributive shock characterized by mean arterial pressure of less than 65 mmHg, with normal to high cardiac output and often refractory to fluid resuscitation, high doses of intravenous vasopressors, and inotropes. It is usually observed after cardiac and solid organ transplantation surgeries. Here, we report a 56-year-old female patient who presented with a profound vasoplegia manifesting as lethargy and confusion in the setting of amlodipine toxicity. This case of severe vasoplegia was refractory to all conditional lines of medical management reported in the literature. The mainstay treatment modalities for vasoplegia include volume resuscitation, catecholamines, vasopressin, angiotensin II, and possibly methylene blue in unresponsive cases. Our patient was given hydroxocobalamin in favor of methylene blue, given the history of serotonin reuptake inhibitors use, which would have caused a life-threatening serotonin syndrome. Hydroxycobolamine resulted in a dramatic clinical recovery, suggesting its potentially significant role in refractory vasoplegia. Cureus 2023-05-01 /pmc/articles/PMC10231868/ /pubmed/37265888 http://dx.doi.org/10.7759/cureus.38400 Text en Copyright © 2023, Ayasa et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Emergency Medicine
Ayasa, Laith A
Azar, Jehad
Odeh, Anas
Ayyad, Mohammed
Shbaita, Sara
Zidan, Thabet
Awwad, Noor Al-deen
Kawa, Nagham M
Awad, Wafaa
Hydroxocobalamin as Rescue Therapy in a Patient With Refractory Amlodipine-Induced Vasoplegia
title Hydroxocobalamin as Rescue Therapy in a Patient With Refractory Amlodipine-Induced Vasoplegia
title_full Hydroxocobalamin as Rescue Therapy in a Patient With Refractory Amlodipine-Induced Vasoplegia
title_fullStr Hydroxocobalamin as Rescue Therapy in a Patient With Refractory Amlodipine-Induced Vasoplegia
title_full_unstemmed Hydroxocobalamin as Rescue Therapy in a Patient With Refractory Amlodipine-Induced Vasoplegia
title_short Hydroxocobalamin as Rescue Therapy in a Patient With Refractory Amlodipine-Induced Vasoplegia
title_sort hydroxocobalamin as rescue therapy in a patient with refractory amlodipine-induced vasoplegia
topic Emergency Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10231868/
https://www.ncbi.nlm.nih.gov/pubmed/37265888
http://dx.doi.org/10.7759/cureus.38400
work_keys_str_mv AT ayasalaitha hydroxocobalaminasrescuetherapyinapatientwithrefractoryamlodipineinducedvasoplegia
AT azarjehad hydroxocobalaminasrescuetherapyinapatientwithrefractoryamlodipineinducedvasoplegia
AT odehanas hydroxocobalaminasrescuetherapyinapatientwithrefractoryamlodipineinducedvasoplegia
AT ayyadmohammed hydroxocobalaminasrescuetherapyinapatientwithrefractoryamlodipineinducedvasoplegia
AT shbaitasara hydroxocobalaminasrescuetherapyinapatientwithrefractoryamlodipineinducedvasoplegia
AT zidanthabet hydroxocobalaminasrescuetherapyinapatientwithrefractoryamlodipineinducedvasoplegia
AT awwadnooraldeen hydroxocobalaminasrescuetherapyinapatientwithrefractoryamlodipineinducedvasoplegia
AT kawanaghamm hydroxocobalaminasrescuetherapyinapatientwithrefractoryamlodipineinducedvasoplegia
AT awadwafaa hydroxocobalaminasrescuetherapyinapatientwithrefractoryamlodipineinducedvasoplegia